Coeptis Therapeutics Holdings, Inc. received an extension until January 15, 2025, to regain compliance with Nasdaq's minimum bid price requirement after failing to meet it by the previous deadline of July 29, 2024.
AI Assistant
COEPTIS THERAPEUTICS HOLDINGS INC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.